{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:47:32Z","timestamp":1789386452708,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/wnf.0b013e31820d6699","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T16:34:33Z","timestamp":1298738073000},"page":"66-70","source":"Crossref","is-referenced-by-count":45,"title":["The Emergence of Devastating Impulse Control Disorders During Dopamine Agonist Therapy of the Restless Legs Syndrome"],"prefix":"10.1097","volume":"34","author":[{"given":"Dien","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cunnington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Swieca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.54.5.1064","article-title":"Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly.","volume":"54","author":"Rothdach","year":"2000","journal-title":"Neurology"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/mds.1209","article-title":"Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.","volume":"16","author":"Ulfberg","year":"2001","journal-title":"Mov Disord"},{"key":"R4-3-20210203","first-page":"739","article-title":"Restless legs syndrome and sleep bruxism: prevalence and association among Canadians.","volume":"17","author":"Lavigne","year":"1994","journal-title":"Sleep"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/01.wnl.0000168910.48309.4a","article-title":"Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.","volume":"65","author":"Tison","year":"2005","journal-title":"Neurology"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/gerona\/glp161","article-title":"Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study.","volume":"65","author":"Celle","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4065\/79.7.916","article-title":"An algorithm for the management of restless legs syndrome.","volume":"79","author":"Silber","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease.","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R9-3-20210203","first-page":"62","article-title":"Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson's disease-presentation of four cases.","volume":"5","author":"Serrano-Duenas","year":"2002","journal-title":"German J Psychiatry"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of pathological gambling in patients with Parkinson's disease.","volume":"21","author":"Avanzi","year":"2006","journal-title":"Mov Disord"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10072-004-0238-z","article-title":"Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.","volume":"25","author":"Avanzi","year":"2004","journal-title":"Neurol Sci"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease.","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"R13-3-20210203","first-page":"S93","article-title":"Dopamine and impulse control disorders in Parkinson's disease.","volume":"64","author":"Weintraub","year":"2008","journal-title":"Ann Neurol"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(97)01078-0","article-title":"D3 dopamine receptor mRNA is widely expressed in the human brain.","volume":"779","author":"Suzuki","year":"1998","journal-title":"Brain Res"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4088\/JCP.v66n0504","article-title":"Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"66","author":"Petry","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.","volume":"22","author":"Gallagher","year":"2007","journal-title":"Mov Disord"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","article-title":"Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.","volume":"30","author":"Driver-Dunckley","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2006.10.001","article-title":"Pathological gambling associated with dopamine agonist use in restless legs syndrome.","volume":"13","author":"Quickfall","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","article-title":"Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.","volume":"68","author":"Tippmann-Peikert","year":"2007","journal-title":"Neurology"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2009.11.010","article-title":"Compulsive habits in restless legs syndrome patients under dopaminergic treatment.","volume":"290","author":"Pourcher","year":"2010","journal-title":"J Neurol Sci"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale.","volume":"51","author":"Patton","year":"1995","journal-title":"J Clin Psychol"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.paid.2009.04.008","article-title":"Fifty years of the Barratt Impulsiveness Scale: an update and review.","volume":"47","author":"Stanford","year":"2009","journal-title":"Pers Indiv Differ"},{"key":"R24-3-20210203","first-page":"5","article-title":"Compulsive buying: descriptive characteristics and psychiatric comorbidity.","volume":"55","author":"Christenson","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease.","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mds.10518","article-title":"Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.","volume":"18","author":"Herzog","year":"2003","journal-title":"Mov Disord"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"R29-3-20210203","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.","volume":"110","author":"Gerlach","year":"2003","journal-title":"J Neural Transm"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/clpt.2009.6","article-title":"Genes and addictions.","volume":"85","author":"Bevilacqua","year":"2009","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31820d6699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:14:45Z","timestamp":1620976485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201103000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31820d6699","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}